Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,762 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A comparative study of depressive and anxiety symptoms, insomnia, and sleepiness in patients with obstructive sleep apnea, restless legs syndrome, or both (CO-ROSA): preliminary findings from a retrospective study.
DelRosso LM, Bradshaw S, Singh A, Jain V, Mogavero MP, Ferri R. DelRosso LM, et al. Among authors: singh a. Int Clin Psychopharmacol. 2024 Dec 23. doi: 10.1097/YIC.0000000000000571. Online ahead of print. Int Clin Psychopharmacol. 2024. PMID: 39704028
Age matters: association between age and depression severity at the time of OSA diagnosis and PAP adherence in adult patients.
Niraula R, Singh A, DelRosso LM, Meghpara S, Keenan L. Niraula R, et al. Among authors: singh a. J Clin Sleep Med. 2024 Jun 1;20(6):859-862. doi: 10.5664/jcsm.10992. J Clin Sleep Med. 2024. PMID: 38189369
There was a statistically significant difference in age between both groups (P = .031). Spearman correlation confirmed a negative, statistically significant correlation between PHQ-9 scores and age in patients with OSA. ...Our findings can help identify high-risk de …
There was a statistically significant difference in age between both groups (P = .031). Spearman correlation confirmed a negat …
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy.
Elghawy O, Barsouk A, Reed-Guy L, Stalker M, Sussman J, Robinson K, Kosteva J, Singh A, Cohen RB, Langer C, Ciunci C, D'Avella C, Sun L, Marmarelis ME, Aggarwal C. Elghawy O, et al. Among authors: singh a. Clin Lung Cancer. 2024 Dec 13:S1525-7304(24)00263-8. doi: 10.1016/j.cllc.2024.11.014. Online ahead of print. Clin Lung Cancer. 2024. PMID: 39743378 No abstract available.
Cardiac events and dynamic echocardiographic and electrocardiogram changes following osimertinib treatment in lung cancer.
Le JN, Gasho JO, Peony O, Singh A, Silos KD, Kim S, Nguyen AT, Kamrava M, Mirhadi A, Hakimian B, Reckamp KL, Sankar K, Mak RH, Nikolova AP, Atkins KM. Le JN, et al. Among authors: singh a. Front Cardiovasc Med. 2024 Dec 16;11:1485033. doi: 10.3389/fcvm.2024.1485033. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39741660 Free PMC article.
25,762 results
You have reached the last available page of results. Please see the User Guide for more information.